Pfizer issues 2025 outlook in-line with Wall Street, shares rise

Nvidia's slide continues as stock tumbles over 10% from recent record

Tue, Dec 17, 2024, 8:09 AM

Pfizer's (PFE) stock moved higher in Tuesday's pre-market trading after the pharmaceutical giant issued an upbeat full-year outlook for 2025. The company projected annual sales between $61 billion and $64 billion, with earnings per share estimates at $2.80 to $3 — both metrics coming in line with Wall Street projections.

Additionally, the company reaffirmed its 2024 full-year guidance, estimating earnings per share between $2.75 and $2.95.

Morning Brief anchors Seana Smith and Brad Smith break down the details and weigh in on the company's outlook on PBM (pharmacy benefit manager) reform.

To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.

This post was written by Angel Smith